Rita Leporati
@ritalepp
Medical Oncologist, thoracic malignancies @IstTumori
ID: 484620881
06-02-2012 09:40:26
60 Tweet
527 Followers
506 Following
Can Bone Targeted Agents’ use enhance ICI efficacy in aNSCLC pts with bone mets? ➡️ Take a look to out study on Lung Cancer Journal showing a survival benefit upon concomitant #ICI and #denosumab administration in #aNSCLC pts with high bone tumor burden #HBTB Roberto Ferrara
It was a great honor for me today to discuss the PEANUT trial update to #AIOM. Pembrolizumab + nab-paclitaxel confirmed a significant efficacy in #mUC over 4 years of mFUP. ‼️ORR 50.0%; DCR 75.8% ‼️mPFS 5.1 mo; mOS 11.0 mo My thanks to the GU Oncology Team of Istituto Tumori
Evidence on immune predictors is fragmented, thus requiring caution. That said, this retrospective study highlights early modifications of lymphocyte counts on CDK4/6i-ET are associated w/ better PFS & OS in pts w/ met HR+/HER2− #breastcancer shorturl.at/zBGM8 Therapeutic Advances in Medical Oncology
APOLLO 11 Project, Consortium in Advanced #Lung #Cancer Patients Treated With #Innovative #Therapies: Integration of Real-World Data and Translational Research - Clinical Lung Cancer using #ArtificialIntelligence to analyze the data. #datadriven #model clinical-lung-cancer.com/article/S1525-…
What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in Cancer Discovery today rb.gy/q484j9 Tweetorial👇
Our IASLC Academy is meeting today again!!, very happy to help young oncologists at the begining of their career! Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation #LCSM NO. #LungCancer Fawzi Abu Rous, MD @esinghimd Kaushal Parikh Aakash Desai, MD, MPH SOFIA VIDAURRE MENDES Ramila David D. W. Lee. Rita Leporati Balazs Halmos
Why do some patients benefit less than others from precision cancer medicine? We are excited to share our paper "Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling” out in Nature Communications. nature.com/articles/s4146… 🧵
Don’t miss the V edition of the #CocktailWithScience #LungCancer meeting in Milan🫁 👉🏻 lungcancer-milan.com Hosted by Giuseppe Lo Russo with a world-class faculty
Faculty and meentees of our IASLC academy that is meeting today at #WCLC24 with Christian Rolfo Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation Balazs Halmos Eric K. Singhi, MD Triparna Sen (Sen-Lab) Marina Garassino LudaBazhenovaMD Jyoti D Patel Aakash Desai, MD, MPH and many others! #lungcancer #lcsm SOFIA VIDAURRE MENDES